Sun Pharmaceutical Industries Limited

NSE SUNPHARMA.NS

Sun Pharmaceutical Industries Limited Price to Book Ratio (P/B) on January 14, 2025: 6.36

Sun Pharmaceutical Industries Limited Price to Book Ratio (P/B) is 6.36 on January 14, 2025, a 12.36% change year over year. Price to book ratio compares the stock price to the book value per share; above 1 indicates market values company more than its book value.
  • Sun Pharmaceutical Industries Limited 52-week high Price to Book Ratio (P/B) is 7.33 on September 27, 2024, which is 15.21% above the current Price to Book Ratio (P/B).
  • Sun Pharmaceutical Industries Limited 52-week low Price to Book Ratio (P/B) is 5.38 on June 04, 2024, which is -15.42% below the current Price to Book Ratio (P/B).
  • Sun Pharmaceutical Industries Limited average Price to Book Ratio (P/B) for the last 52 weeks is 6.39.
Key data
Date Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield Price to Earnings Ratio (P/E)
Market news
Loading...
NSE: SUNPHARMA.NS

Sun Pharmaceutical Industries Limited

CEO Mr. Dilip Shantilal Shanghvi
IPO Date Jan. 1, 1996
Location India
Headquarters Sun House
Employees 43,000
Sector Health Care
Industries
Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, ophthalmology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances; generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications, as well as over-the-counter products. The company was founded in 1983 and is based in Mumbai, India.

Similar companies

LUPIN.NS

Lupin Limited

USD 24.89

0.15%

AXISBANK.NS

Axis Bank Limited

USD 12.15

0.37%

CIPLA.NS

Cipla Limited

USD 16.73

0.74%

HCLTECH.NS

HCL Technologies Limited

USD 20.95

-8.71%

DRREDDY.NS

Dr. Reddy's Laboratories Limited

USD 15.45

0.33%

StockViz Staff

January 15, 2025

Any question? Send us an email